Conference Coverage
Conference Coverage
Intravascular lithotripsy hailed as ‘game changer’ for coronary calcification
Positive results reported from the U.S. pivotal Disrupt CAD III study sets stage for regulatory approval.
Conference Coverage
Fauci: Cautious optimism for COVID-19 vaccine by end of 2020
Top health official is “cautiously optimistic” for vaccine distribution before end of year, pending favorable safety and efficacy data.
Conference Coverage
NACMI: Clear benefit with PCI in STEMI COVID-19 patients
Angiography fell off but door-to-balloon times haven’t suffered, even with the pandemic, according to initial results from the North American...
Conference Coverage
Ticagrelor monotherapy beats DAPT in STEMI
One-year results of the randomized TICO-STEMI trial suggests aspirin can be dropped safely after 3 months, but the findings need confirmation,...
Conference Coverage
T2D treatments create tension between glycemic and cardiovascular goals
Recent society guidelines clash on whether metformin or newer drug classes should start first when treating patients with type 2 diabetes.
Conference Coverage
Empagliflozin cut PA pressures in heart failure patients
The drops in pulmonary artery pressure were modest but large enough to be clinically meaningful, they appeared quickly, and increased over time....
Conference Coverage
COVID-19 vaccine hesitancy ‘somewhat understandable,’ expert says
Dr. Offit predicts a vaccine may be able to be 75%-80% effective at preventing mild to moderate disease.
Conference Coverage
Pediatric fractures shift during pandemic
Conference Coverage
Hidradenitis suppurativa therapy options should be patient guided
The most difficult symptoms for one patient, such as pain or persistent abscess drainage, might not be the same for another.
Conference Coverage
EMPEROR-Reduced: Empagliflozin’s HFrEF benefit holds steady on top of sacubitril/valsartan
Conference Coverage
Dapagliflozin’s CKD performance sends heart failure messages
The recently reported DAPA-CKD trial results focused on patients with renal disease, but the findings also resonate for heart failure clinicians...